Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae.

The Journal of Infectious Diseases
Douglas M WarnerAnn E Jerse

Abstract

The Neisseria gonorrhoeae MtrC-MtrD-MtrE multidrug-resistance efflux pump expels macrolide antibiotics, penicillin, and antimicrobial effectors of the innate defense. Mutation of the mtrR locus, which encodes a transcriptional repressor of the mtrCDE operon, increases gonococcal resistance to these agents. Here we report that, in a mouse infection model, an mtrR mutant is more fit than the wild-type bacteria. Consistent with derepression of the mtrCDE operon as the primary reason for the fitness benefit, an mtrR,mtrE double mutant and an mtrE mutant showed no difference in survival phenotype. Gonococcal mutants deficient in MtrA, an activator of the mtrCDE operon, exhibited significantly reduced fitness in vivo, and mtrA mutants with spontaneous compensatory mtrR mutations were selected during infection. These results confirm the importance of the MtrC-MtrD-MtrE efflux-pump system during experimental gonococcal genital-tract infection and also illustrate an antibiotic-resistance mechanism that is accompanied by a fitness benefit rather than a fitness cost.

References

Jul 1, 1995·Journal of Bacteriology·K E Hagman, W M Shafer
Jan 1, 1994·Methods in Enzymology·S Welkos, A O'Brien
Mar 1, 1997·Molecular Microbiology·I J Mehr, H S Seifert
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·W M ShaferR I Lehrer
Jun 18, 1999·Annals of the New York Academy of Sciences·A D Van Beuzekom, J A Van Gisbergen
Jul 3, 2002·The Journal of Experimental Medicine·Yoichi HirakataDavid P Speert
Oct 31, 2002·The Journal of Antimicrobial Chemotherapy·Patricia SánchezJosé L Martínez
Jan 21, 2003·Journal of Bacteriology·Corinne Rouquette-LoughlinWilliam M Shafer
Jan 24, 2004·The Journal of Antimicrobial Chemotherapy·Ana AlonsoJose L Martinez
Jan 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Naidan LuoQijing Zhang
May 20, 2005·Journal of Bacteriology·Jason P Folster, William M Shafer
Jul 5, 2005·Journal of Bacteriology·Katherine M HoffmannRichard G Brennan
Jul 21, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John W Tapsall
Sep 16, 2005·The Journal of Antimicrobial Chemotherapy·Corinne E Rouquette-LoughlinWilliam M Shafer
Aug 15, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·H Nikaido
Nov 28, 2006·Animal Biotechnology·H HarbottleD G White

❮ Previous
Next ❯

Citations

Apr 8, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Kristin HegstadSiamak P Yazdankhah
Apr 12, 2012·The Journal of Infectious Diseases·Jo-Anne R Dillon, Rajinder P Parti
Jan 5, 2012·Antimicrobial Agents and Chemotherapy·Alexandra Dubon MercanteWilliam M Shafer
Jan 20, 2011·Infection and Immunity·Rachel A VonckAnn E Jerse
Nov 4, 2008·Journal of Bacteriology·Jason P FolsterWilliam M Shafer
Aug 15, 2009·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Dec 13, 2012·Future Microbiology·Magnus Unemo, Robert A Nicholas
Feb 28, 2014·Future Microbiology·Paula Bianca BlomquistBambos M Charalambous
Jul 18, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter A Rice
May 12, 2011·Cellular and Molecular Life Sciences : CMLS·Tomaz Koprivnjak, Andreas Peschel
Jan 26, 2016·Critical Reviews in Microbiology·Jennifer L EdwardsKate L Seib
Aug 12, 2009·Current Opinion in Microbiology·Jessica M A Blair, Laura J V Piddock
Aug 21, 2009·The FEBS Journal·Manuela DietrichAlexandra Friedrich
Aug 8, 2008·Cellular Microbiology·Alison K Criss, H Steven Seifert
Jan 14, 2012·Annals of the New York Academy of Sciences·Magnus Unemo, William M Shafer
Feb 24, 2015·Biochimica Et Biophysica Acta·Margaret E Bauer, William M Shafer
Oct 12, 2011·Journal of Microbiological Methods·Guocai LiMingchun Ji
Jun 1, 2012·Expert Opinion on Pharmacotherapy·Juliet E Stoltey, Pennan M Barry
Feb 12, 2009·FEMS Microbiology Reviews·Jose Luis MartinezCarolina Alvarez-Ortega
Jun 8, 2011·FEMS Microbiology Reviews·José L Martínez, Fernando Rojo
Nov 5, 2014·Antimicrobial Agents and Chemotherapy·Elizabeth A OhneckWilliam M Shafer
Sep 14, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Sara Hernando-AmadoJosé L Martínez
Oct 21, 2016·MicrobiologyOpen·Kyle A TiptonPhilip N Rather
Mar 16, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gabriella SpenglerLeonard Amaral
Feb 13, 2018·Nature Reviews. Microbiology·Sarah Jane Quillin, H Steven Seifert
Sep 30, 2016·Microorganisms·Paula BlancoJose Luis Martinez
Mar 28, 2018·Infection and Immunity·Zhemin WangStijn van der Veen
Sep 11, 2018·Expert Opinion on Drug Discovery·Paula BlancoManuel Alcalde-Rico
Jul 2, 2014·Clinical Microbiology Reviews·Magnus Unemo, William M Shafer

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.